Saluda Medical closed a $100 million finance round, the spine company said Jan. 10.
Financing was led by Redmile Group and other existing investors, according to a news release. The money will support commercialization of the Evoke closed-loop spinal cord stimulator.
Saluda’s Evoke system is the first designed to sense and measure neural responses and automatically adjust therapy.
Centinel Spine, a global medical device company, reported a 33% increase in year-over-year revenue during the first quarter of 2025. …
Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous…
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and…
Comments are closed.